The lymphocytic cholinergic system and its modulation by organophosphorus pesticides

Maciej Tarkowski1, Waldemar Lutz, Sarah Birindelli

  • 1Department of Immunotoxicology, Nofer Insitute of Occupational Medicine, Lódź, Poland. maciekt@imp.lodz.pl

Insights

Pesticide exposure may impact the neural and immune systems, particularly affecting lymphocytes. Further research into these interactions could lead to early detection methods for adverse effects.

Area of Science:

  • Neuroimmunology
  • Environmental Toxicology
  • Immunotoxicology

Background:

  • The neural and immune systems form a complex network for host defense against pathogens and internal inflammation.
  • Pesticide exposure is a growing concern with potential implications for these interconnected systems.
  • The cholinergic lymphocytic system is a key area where neural and immune interactions are relevant to pesticide effects.

Purpose of the Study:

  • To review the interactions between the neural and immune systems concerning pesticide exposure.
  • To discuss how cellular and soluble immune components might be affected by pesticides.
  • To propose that studying pesticide effects on lymphocytes can aid in developing early adverse effect detection methods.

Main Methods:

  • Literature review of clinical and basic research on neuro-immune interactions.
  • Analysis of studies investigating pesticide effects on the immune system, specifically lymphocytes.
  • Exploration of the cholinergic system's role in pesticide-induced immunomodulation.

Main Results:

  • Pesticides can influence the neural-immune axis, particularly impacting the cholinergic lymphocytic system.
  • Both cellular and soluble immune components are susceptible to adverse effects from pesticide exposure.
  • Existing research highlights the intricate relationship between pesticide exposure and immune dysregulation.

Conclusions:

  • Understanding pesticide impacts on lymphocytes is crucial for assessing neuro-immune system health.
  • In-depth studies on pesticide-lymphocyte interactions may yield sensitive biomarkers for early toxicity detection.
  • This research area holds potential for developing novel diagnostic tools for environmental health risks.

Related Concept Videos

Anticholinesterase Agents: Poisoning and Treatment01:26

Anticholinesterase Agents: Poisoning and Treatment

Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.     
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...
Indirect-Acting Cholinergic Agonists: Pharmacokinetics01:22

Indirect-Acting Cholinergic Agonists: Pharmacokinetics

Indirect-acting cholinergic agonists, or anticholinesterases, enhance the body's cholinergic activity by inhibiting acetylcholine's breakdown. They are categorized as reversible or irreversible agents based on their mechanism of action. They are further classified into short-acting, intermediate-acting, and long-acting agents based on their duration of action.
Reversible agents containing quaternary amines, such as neostigmine and edrophonium, are not easily absorbed orally because they are...
Indirect-Acting Cholinergic Agonists: Mechanism of Action01:18

Indirect-Acting Cholinergic Agonists: Mechanism of Action

Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex, leading to...
Direct-Acting Cholinergic Agonists: Pharmacokinetics01:31

Direct-Acting Cholinergic Agonists: Pharmacokinetics

Direct-acting cholinergic agonists, such as synthetic choline esters and naturally occurring alkaloids, exert their effects by enhancing the actions of acetylcholine and stimulating the parasympathetic nervous system. Synthetic choline esters share structural similarities with acetylcholine. For example, they have a positively charged quaternary ammonium or onium group, contributing to their hydrophilic characteristics. As a result, they are poorly absorbed in the body through oral...
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship01:29

Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship

Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Indirect-Acting Cholinergic Agonists: Pharmacological Actions01:30

Indirect-Acting Cholinergic Agonists: Pharmacological Actions

Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...